This is not the most recent version of the article. View current version (16 JUL 2013)

Intervention Protocol

Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism

  1. Susan R Kahn1,*,
  2. David R Morrison2,
  3. Jessica Emed3,
  4. Vicky Tagalakis1,
  5. Ian Shrier2

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 20 JAN 2010

DOI: 10.1002/14651858.CD008201


How to Cite

Kahn SR, Morrison DR, Emed J, Tagalakis V, Shrier I. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD008201. DOI: 10.1002/14651858.CD008201.

Author Information

  1. 1

    McGill University, Division of Internal Medicine and Department of Medicine, Montreal, Quebec, Canada

  2. 2

    SMBD-Jewish General Hospital, McGill University, Centre for Clinical Epidemiology and Community Studies, Montreal, Quebec, Canada

  3. 3

    Jewish General Hospital, Department of Nursing, Montreal, Quebec, Canada

*Susan R Kahn, Division of Internal Medicine and Department of Medicine, McGill University, Montreal, Quebec, H3T-1E2, Canada. Susan.Kahn@mcgill.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 20 JAN 2010

SEARCH

This is not the most recent version of the article. View current version (16 JUL 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to determine the effectiveness of interventions designed to increase the implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for VTE. Effectiveness will be assessed in terms of:

  1. Increase in proportion of appropriate use of thromboprophylaxis.
  2. Reduction in proportion of clinically diagnosed VTE (all VTE; DVT (any, proximal, distal); PE and fatal PE).
  3. Reduction in proportion of asymptomatic VTE (as detected by systematic screening of patients who do not have symptoms of DVT or PE.